These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33350862)

  • 1. Melatonin and regulation of miRNAs: novel targeted therapy for cancerous and noncancerous disease.
    Pourhanifeh MH; Mehrzadi S; Hosseinzadeh A
    Epigenomics; 2021 Jan; 13(1):65-81. PubMed ID: 33350862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor and Protective Effects of Melatonin: The Potential Roles of MicroRNAs.
    Ashrafizadeh M; Ahmadi Z; Yaribeygi H; Sathyapalan T; Jamialahmadi T; Sahebkar A
    Adv Exp Med Biol; 2021; 1328():463-471. PubMed ID: 34981497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Therapeutic Effects of Melatonin Mediate via miRNAs in Cancer.
    Pourmohammad P; Maroufi NF; Rashidi M; Vahedian V; Pouremamali F; Faridvand Y; Ghaffari-Novin M; Isazadeh A; Hajazimian S; Nejabati HR; Nouri M
    Biochem Genet; 2022 Feb; 60(1):1-23. PubMed ID: 34181134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple interactions between melatonin and non-coding RNAs in cancer biology.
    Maleki M; Khelghati N; Alemi F; Younesi S; Asemi Z; Abolhasan R; Bazdar M; Samadi-Kafil H; Yousefi B
    Chem Biol Drug Des; 2021 Sep; 98(3):323-340. PubMed ID: 33905613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin restrains angiogenic factors in triple-negative breast cancer by targeting miR-152-3p: In vivo and in vitro studies.
    Marques JHM; Mota AL; Oliveira JG; Lacerda JZ; Stefani JP; Ferreira LC; Castro TB; Aristizábal-Pachón AF; Zuccari DAPC
    Life Sci; 2018 Sep; 208():131-138. PubMed ID: 29990486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of melatonin on miRNAs modulation in triple-negative breast cancer cells.
    Ferreira LC; Orso F; Dettori D; Lacerda JZ; Borin TF; Taverna D; Zuccari DAPC
    PLoS One; 2020; 15(2):e0228062. PubMed ID: 32012171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA and gene expression analysis of melatonin-exposed human breast cancer cell lines indicating involvement of the anticancer effect.
    Lee SE; Kim SJ; Youn JP; Hwang SY; Park CS; Park YS
    J Pineal Res; 2011 Oct; 51(3):345-52. PubMed ID: 21615491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Potential of Melatonin in the Regulation of MiR-148a-3p and Angiogenic Factors in Breast Cancer.
    Lacerda JZ; Ferreira LC; Lopes BC; Aristizábal-Pachón AF; Bajgelman MC; Borin TF; Zuccari DAPC
    Microrna; 2019; 8(3):237-247. PubMed ID: 30806335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of miRNA expression profiles in melatonin-exposed GC-1 spg cell line.
    Zhu X; Chen S; Jiang Y; Xu Y; Zhao Y; Chen L; Li C; Zhou X
    Gene; 2018 Feb; 642():513-521. PubMed ID: 29197587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Targeting of microRNAs in Cancer: Future Perspectives.
    Tutar L; Tutar E; Özgür A; Tutar Y
    Drug Dev Res; 2015 Nov; 76(7):382-8. PubMed ID: 26435382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications.
    Wang Y; Wang L; Chen C; Chu X
    Mol Cancer; 2018 Feb; 17(1):22. PubMed ID: 29415727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of microRNAs by natural agents: new strategies in cancer therapies.
    Phuah NH; Nagoor NH
    Biomed Res Int; 2014; 2014():804510. PubMed ID: 25254214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis of microRNA networks regulated by melatonin in cancer: Portrait of potential candidates for breast cancer treatment.
    Chuffa LGA; Carvalho RF; Justulin LA; Cury SS; Seiva FRF; Jardim-Perassi BV; Zuccari DAPC; Reiter RJ
    J Pineal Res; 2020 Nov; 69(4):e12693. PubMed ID: 32910542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative Disorders.
    Gupta S; Verma S; Mantri S; Berman NE; Sandhir R
    Drug Dev Res; 2015 Nov; 76(7):397-418. PubMed ID: 26359796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A step-by-step microRNA guide to cancer development and metastasis.
    Markopoulos GS; Roupakia E; Tokamani M; Chavdoula E; Hatziapostolou M; Polytarchou C; Marcu KB; Papavassiliou AG; Sandaltzopoulos R; Kolettas E
    Cell Oncol (Dordr); 2017 Aug; 40(4):303-339. PubMed ID: 28748501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin Inhibits the Proliferation of Gastric Cancer Cells Through Regulating the miR-16-5p-Smad3 Pathway.
    Zhu C; Huang Q; Zhu H
    DNA Cell Biol; 2018 Mar; 37(3):244-252. PubMed ID: 29359963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting miRNAs by natural products: A new way for cancer therapy.
    Zhang B; Tian L; Xie J; Chen G; Wang F
    Biomed Pharmacother; 2020 Oct; 130():110546. PubMed ID: 32721631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs as critical regulators involved in regulating epithelial- mesenchymal transition.
    Zhao X; Lu Y; Nie Y; Fan D
    Curr Cancer Drug Targets; 2013 Nov; 13(9):935-44. PubMed ID: 24168189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling of miRNAs-FOXM1 in cancer and potential targeted therapy.
    Shi M; Cui J; Xie K
    Curr Drug Targets; 2013 Sep; 14(10):1192-202. PubMed ID: 23834153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Roles of miR-25 and its Targeted Genes in Development of Human Cancer.
    Caiazza C; Mallardo M
    Microrna; 2016; 5(2):113-119. PubMed ID: 27594089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.